TN-201

· Tenaya Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TN-201, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM [Phase 1, Phase 2]

See pricing